Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 7 | $1,011,778 |
Sells | 131 | $11,680,571 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
23 Nov 2022 16:14 | ARDX | ARDELYX Inc | RENZ JUSTIN A | Chief Financial Officer | 22 Nov 2022 | Sale | 1,443 | 1.9493 | 2,813 | D |
23 Nov 2022 16:14 | ARDX | ARDELYX Inc | RENZ JUSTIN A | Chief Financial Officer | 22 Nov 2022 | Sale | 61 | 1.9415 | 118 | D |
23 Nov 2022 16:13 | ARDX | ARDELYX Inc | WILLIAMS LAURA A | Chief Medical Officer | 22 Nov 2022 | Sale | 1,193 | 1.9493 | 2,326 | D |
23 Nov 2022 16:13 | ARDX | ARDELYX Inc | WILLIAMS LAURA A | Chief Medical Officer | 22 Nov 2022 | Sale | 33 | 1.945 | 64 | D |
23 Nov 2022 16:13 | ARDX | ARDELYX Inc | WILLIAMS LAURA A | Chief Medical Officer | 22 Nov 2022 | Sale | 15 | 1.9416 | 29 | D |
23 Nov 2022 16:12 | ARDX | ARDELYX Inc | BLANKS ROBERT | See Remarks | 22 Nov 2022 | Sale | 1,405 | 1.9493 | 2,739 | D |
23 Nov 2022 16:12 | ARDX | ARDELYX Inc | BLANKS ROBERT | See Remarks | 22 Nov 2022 | Sale | 26 | 1.9416 | 50 | D |
23 Nov 2022 16:12 | ARDX | ARDELYX Inc | BLANKS ROBERT | See Remarks | 22 Nov 2022 | Sale | 33 | 1.9415 | 64 | D |
17 Nov 2022 16:07 | ARDX | ARDELYX Inc | MOTT DAVID M | Director | 17 Nov 2022 | Purchase | 567,000 | 1.7648 | 1,000,642 | D |
07 Oct 2022 16:06 | ARDX | ARDELYX Inc | BLANKS ROBERT | See Remarks | 05 Oct 2022 | Sale | 100,000 | 1.5 | 150,000 | D |
01 Sep 2022 19:05 | ARDX | ARDELYX Inc | FELSCH ROBERT ORA | See Remarks | 31 Aug 2022 | Purchase | 3,000 | 0.6188 | 1,856 | D |
01 Sep 2022 19:04 | ARDX | ARDELYX Inc | ROSENBAUM DAVID P. | Chief Development Officer | 01 Sep 2022 | Sale | 3,000 | 0.9201 | 2,760 | I |
01 Sep 2022 19:04 | ARDX | ARDELYX Inc | ROSENBAUM DAVID P. | Chief Development Officer | 31 Aug 2022 | Purchase | 3,000 | 0.6188 | 1,856 | I |
01 Sep 2022 19:04 | ARDX | ARDELYX Inc | RENZ JUSTIN A | Chief Financial Officer | 31 Aug 2022 | Purchase | 3,000 | 0.6188 | 1,856 | D |
01 Sep 2022 19:03 | ARDX | ARDELYX Inc | WILLIAMS LAURA A | Chief Medical Officer | 31 Aug 2022 | Purchase | 3,000 | 0.6188 | 1,856 | D |
01 Sep 2022 19:03 | ARDX | ARDELYX Inc | RAAB MICHAEL | President & CEO | 31 Aug 2022 | Purchase | 3,000 | 0.6188 | 1,856 | D |
01 Sep 2022 19:02 | ARDX | ARDELYX Inc | GRAMMER ELIZABETH A | See Remarks | 31 Aug 2022 | Purchase | 3,000 | 0.6188 | 1,856 | D |
29 Aug 2022 16:20 | ARDX | ARDELYX Inc | BLANKS ROBERT | See Remarks | 26 Aug 2022 | Sale | 21,842 | 1.0399 | 22,713 | D |
24 Aug 2022 17:45 | ARDX | ARDELYX Inc | RODRIGUEZ SUSAN | Chief Commercial Officer | 22 Aug 2022 | Sale | 64 | 0.9801 | 63 | D |
24 Aug 2022 17:45 | ARDX | ARDELYX Inc | RODRIGUEZ SUSAN | Chief Commercial Officer | 22 Aug 2022 | Sale | 3,356 | 0.9837 | 3,301 | D |
24 Aug 2022 17:45 | ARDX | ARDELYX Inc | ROSENBAUM DAVID P. | Chief Development Officer | 22 Aug 2022 | Sale | 1 | 0.9801 | 1 | I |
24 Aug 2022 17:45 | ARDX | ARDELYX Inc | ROSENBAUM DAVID P. | Chief Development Officer | 22 Aug 2022 | Sale | 496 | 0.9837 | 488 | I |
24 Aug 2022 17:45 | ARDX | ARDELYX Inc | ROSENBAUM DAVID P. | Chief Development Officer | 22 Aug 2022 | Sale | 17 | 0.9801 | 17 | D |
24 Aug 2022 17:45 | ARDX | ARDELYX Inc | ROSENBAUM DAVID P. | Chief Development Officer | 22 Aug 2022 | Sale | 1,441 | 0.9837 | 1,418 | D |
24 Aug 2022 17:44 | ARDX | ARDELYX Inc | BLANKS ROBERT | See Remarks | 22 Aug 2022 | Sale | 17 | 0.9801 | 17 | D |
24 Aug 2022 17:44 | ARDX | ARDELYX Inc | BLANKS ROBERT | See Remarks | 22 Aug 2022 | Sale | 1,441 | 0.9837 | 1,418 | D |
24 Aug 2022 17:43 | ARDX | ARDELYX Inc | RAAB MICHAEL | President & CEO | 22 Aug 2022 | Sale | 76 | 0.9802 | 74 | D |
24 Aug 2022 17:43 | ARDX | ARDELYX Inc | RAAB MICHAEL | President & CEO | 22 Aug 2022 | Sale | 54 | 0.9801 | 53 | D |
24 Aug 2022 17:43 | ARDX | ARDELYX Inc | RAAB MICHAEL | President & CEO | 22 Aug 2022 | Sale | 6,016 | 0.9837 | 5,918 | D |
24 Aug 2022 17:43 | ARDX | ARDELYX Inc | GRAMMER ELIZABETH A | See Remarks | 22 Aug 2022 | Sale | 9 | 0.9802 | 9 | D |
24 Aug 2022 17:43 | ARDX | ARDELYX Inc | GRAMMER ELIZABETH A | See Remarks | 22 Aug 2022 | Sale | 2 | 0.9801 | 2 | D |
24 Aug 2022 17:43 | ARDX | ARDELYX Inc | GRAMMER ELIZABETH A | See Remarks | 22 Aug 2022 | Sale | 1,225 | 0.9837 | 1,205 | D |
24 Aug 2022 17:42 | ARDX | ARDELYX Inc | WILLIAMS LAURA A | Chief Medical Officer | 22 Aug 2022 | Sale | 13 | 0.9801 | 13 | D |
24 Aug 2022 17:42 | ARDX | ARDELYX Inc | WILLIAMS LAURA A | Chief Medical Officer | 22 Aug 2022 | Sale | 1,263 | 0.9837 | 1,242 | D |
24 Aug 2022 17:42 | ARDX | ARDELYX Inc | RENZ JUSTIN A | Chief Financial Officer | 22 Aug 2022 | Sale | 12 | 0.9801 | 12 | D |
24 Aug 2022 17:42 | ARDX | ARDELYX Inc | RENZ JUSTIN A | Chief Financial Officer | 22 Aug 2022 | Sale | 6 | 0.9802 | 6 | D |
24 Aug 2022 17:42 | ARDX | ARDELYX Inc | RENZ JUSTIN A | Chief Financial Officer | 22 Aug 2022 | Sale | 1,480 | 0.9837 | 1,456 | D |
28 Jul 2022 16:06 | ARDX | ARDELYX Inc | BLANKS ROBERT | See Remarks | 26 Jul 2022 | Sale | 5,188 | 0.67 | 3,476 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)